Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 63187-964

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 63187-964). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Chemical structure diagram of Esomeprazole Magnesium, showing the molecular formula with magnesium ion (Mg2+) and three water molecules (3 H2O).*

FDA Label Image

Figure2 (Figure2)

A line graph depicting the percentage maintained over months for Esomeprazole at 10 mg, 20 mg, 40 mg doses, and placebo. The x-axis represents time in months, labeled from 0 to 6 months, and the y-axis shows percent maintained from 0 to 100. The chart compares the efficacy of different doses and placebo over time.*

FDA Label Image

Figure3 (Figure3)

A line graph depicting the percent maintained over a period of six months. The graph compares four groups: Esomeprazole 40 mg, Esomeprazole 20 mg, Esomeprazole 10 mg, and placebo. Percent maintained is plotted on the vertical axis, and time in months on the horizontal axis. Each group is represented by a distinct line with markers.*

FDA Label Image

Figure4 (Figure4)

A line chart depicting the percent of patients symptom-free over a 28-day study period for Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo groups. The x-axis represents study days, and the y-axis shows the percentage of symptom-free patients, with data points for each treatment group. The chart illustrates comparative efficacy trends among the three groups during the treatment duration.*

FDA Label Image

Figure5 (Figure5)

Line graph showing percent of patients symptom-free over a 28-day diary period comparing Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The graph tracks symptom-free percentages on the y-axis against diary days on the x-axis, illustrating differences in symptom relief over time between the three groups.*

FDA Label Image

63187-964-30 (Container1)

Label for Esomeprazole Magnesium 20 mg delayed-release capsules. The label states the product contains 30 capsules and describes the capsule appearance as pale yellow to brown pellets in a size 4 blue and dark blue hard gelatin shell marked with 'RDY' and '492'. The label includes the NDC 63187-964-30 and lists the manufacturer as Dr. Reddy's Laboratories Limited, India, with the labeler as Proficient Rx LP.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.